Caricamento...

Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

Long-lasting success in lung cancer therapy using tyrosine kinase inhibitors (TKIs) is rare since the tumors develop resistance due to the occurrence of molecularly altered subclones. The aim of this study was to monitor tumors over time based on the quantity of mutant plasma DNA and to identify ear...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sci Rep
Autori principali: Riediger, Anja Lisa, Dietz, Steffen, Schirmer, Uwe, Meister, Michael, Heinzmann-Groth, Ingrid, Schneider, Marc, Muley, Thomas, Thomas, Michael, Sültmann, Holger
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027592/
https://ncbi.nlm.nih.gov/pubmed/27640882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep33505
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !